MEDICINA
Departamento
Masaryk University
Brno, República ChecaPublicaciones en colaboración con investigadores/as de Masaryk University (18)
2024
2023
-
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)
Leukemia
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
-
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 7, pp. 1383-1392
2022
-
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Blood, Vol. 140, Núm. 26, pp. 2773-2787
2020
-
Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools
Frontiers in Immunology, Vol. 11
-
EuroFlow Standardized Approach to Diagnostic Immunopheneotyping of Severe PID in Newborns and Young Children
Frontiers in Immunology, Vol. 11
-
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination
Leukemia, Vol. 34, Núm. 2, pp. 589-603
2019
-
CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
Leukemia, Vol. 33, Núm. 2, pp. 518-558
-
Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies
Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 3, pp. 809-824
-
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
The Lancet Haematology, Vol. 6, Núm. 12, pp. e638-e649
-
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
Leukemia, Vol. 33, Núm. 9, pp. 2254-2265
-
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
Leukemia, Vol. 33, Núm. 9, pp. 2241-2253
2017
-
Next-generation sequencing in chronic lymphocytic leukemia: Recent findings and new horizons
Oncotarget, Vol. 8, Núm. 41, pp. 71234-71248
2016
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
2013
-
Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma
Journal of Clinical Oncology, Vol. 31, Núm. 2, pp. 247-255
2012
-
Report from the European myeloma network on interphase FISH in multiple myeloma and related disorders
Haematologica, Vol. 97, Núm. 8, pp. 1272-1277
2011
-
Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN)
Blood, Vol. 118, Núm. 17, pp. 4519-4529